期刊文献+

炔雌醇环丙孕酮和屈螺酮炔雌醇治疗PCOS的meta分析 被引量:1

Meta analysis of the treatment of PCOS with ethinylestradiol and cyproterone acetate and Drospirenone and Ethinylestradiol
下载PDF
导出
摘要 目的探讨炔雌醇环丙孕酮与屈螺酮炔雌醇在治疗PCOS中的应用价值。方法计算机检索PubMed、中国知网(CNKI)、万方数据库等途径收集相关文献。通过Revman 5.3软件对治疗后BMI、WHR、血糖、胰岛素、性激素等情况进行meta分析。结果共纳入6篇文献,325例患者。Meta分析结果显示:屈螺酮环丙孕酮在降低血睾酮、总胆固醇、低密度脂蛋白方面优于炔雌醇环丙孕酮,但头痛的发生率高于炔雌醇环丙孕酮。结论屈螺酮炔雌醇和炔雌醇环丙孕酮均可用来治疗PCOS,且屈螺酮炔雌醇在降低血睾酮、脂质代谢方面更胜一筹。 Objective To investigate the clinical value of ethynylestradiol cyproprogesterone and drononne estradiol in thetreatment of PCOS.Methods PubMedand (CNKI), Wanfang database were searched by computer.Revman 5.3 software was used toanalyze BMI-WHR,blood glucose,insulin,sex hormone and so on.Results a total of 325 patients were included in 6 literature. Metaanalysisresults showed that the incidence of headache was higher than that of estradiol cycloproprogesterone in reducing serumtestosterone,total cholesterol and low density lipoprotein (LDL),but the incidence of headache was higher than that of paracetamol inthe reduction of serum testosterone,total cholesterol and low density lipoprotein (LDL). Cycloproprogesterone.Conclusion Bothestradiol and cyproprogesterone can be used in the treatment of PCOS,and estradiol is superior in reducing serum testosterone andlipid metabolism.
作者 刘红梅 王晖 LIU Hong-mei;WANG Hui(Department of Obstetrics and Gynecology,the First Affiliated Hospital of Shihezi University,Xinjiang Shihezi 832000,China)
出处 《实用妇科内分泌电子杂志》 2018年第30期1-3,共3页 Electronic Journal of Practical Gynecological Endocrinology
关键词 达英-35 炔雌醇环丙孕酮 优思明 屈螺酮炔雌醇 PCOS 多囊卵巢综合征 Diane-35 Ethinylestradiol and cyproterone acetate Yasmin Drospirenone and Ethinylestrad iol PCOS polycysticovary syndrome
  • 相关文献

参考文献4

二级参考文献39

  • 1陈子江,赵君利,周凤荣,李媛,赵力新,马增香.济南市汉族育龄妇女PCOS患病状况的初步调查[J].现代妇产科进展,2005,14(6):442-444. 被引量:41
  • 2陈秀敏,朱文杰,付志红,李雪梅.卵泡期经阴道小卵泡抽吸治疗多囊卵巢综合征排卵障碍的护理探讨[J].国际医药卫生导报,2006,12(16):64-65. 被引量:2
  • 3赵君利,陈子江,石玉华,耿玲,马增香,李媛,唐蓉.育龄期妇女体毛状况调查及其在多囊卵巢综合征诊断中的初步应用[J].中华妇产科杂志,2007,42(9):590-594. 被引量:15
  • 4Fauser B C, Tarlatzis B C, Rebar R W, et al. Consensus on women's health aspects of polycystic ovary syndrome( P- COS): the Amsterdam ESHRE/ASRM-Sponsored 3rd P- COS Consensus Workshop Group[ J]. Fertil Steril, 2012, 97( 1 ) :28-38.
  • 5Coviello A D, Legro R S, Dunaif A. Adolescent girls with polycystic ovary syndrome have an increased risk of the met- abolic syndrome associated with increasing androgen levels independent of obesity and insulin resistance [ J ]. J Clin Endocrinol Metab, 2006,91 (2) :492-497.
  • 6Vrbikova J, Vondra K, Cibula D, et al. Metabolic syn- drome in young Czech women with polycystic ovary syn- drome [ J ]. Hum Reprod, 2005,20 (12) :3328- 3332.
  • 7Glueek C J, Papanna R, Wang P, et al. Incidence and treatment of metabolic syndrome in newly referred women with confirmed polycystic ovarian syndrome [ J ]. Metabo- lism, 2003,52(7) :908-915.
  • 8Li R, Yu G, Yang D, et al. Prevalence and predictors of metabolic abnormalities in Chinese women with PCOS: a cross-sectional study [ J ]. BMC Endocr Disord, 2014, 14 : 76.
  • 9Soares E M, Azevedo G D, Gadelha R G, et al. Prevalence of the metabolic syndrome and its components in Brazilian women with polycystic ovary syndrome [ J ]. Fertil Steril, 2008,89 (3) :649-655.
  • 10Weerakiet S, Bunnag P, Phakdeekitcharoen B, et al. Prev- alence of the metabolic syndrome in Asian women with poly- cystic ovary syndrome: using the International Diabetes Federation criteria[ J ]. Gynecol Endocrinol, 2007,23 ( 3 ) : 153-160.

共引文献87

同被引文献9

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部